Kelly A. Kramer

October 17, 2026

Snowflake faces downgrade and AI sector sell-off. Snowflake received a downgrade citing higher risk at current prices, while the broader AI sector faced selling pressure following news involving Anthropic. The company continues to expand its ecosystem through new partnerships with Lumen and Benchling to enhance its AI data cloud. These developments occur as the stock trades near its 52-week high, with analysts maintaining a wide range of price targets.

October 17, 2026

Coinbase Partners with Marqeta for Stablecoin Business Cards. Coinbase and Marqeta announced a partnership to offer stablecoin-backed cards to businesses, expanding the company's utility in corporate payments. This move comes as the broader crypto market faces pressure from a hot PPI report and AI trade unwinds. The stock is currently trading near its 52-week low, with technical signals indicating a test of key support levels.

October 4, 2026

Figma Analysts See 25% Upside; Revenue Growth Compared to CrowdStrike. Analysts project a 25% upside for Figma, citing strong product adoption. The company’s revenue growth is being compared to CrowdStrike, highlighting its high‑growth trajectory. Figma is also one of the 32 stocks that both Donald Trump and Cathie Wood have bet on.

October 16, 2026

Gilead Signs $1.9B Deal With Vir For T-Cell Engagers. Gilead Sciences has entered a $1.9 billion partnership with Vir to develop next-generation T-cell engagers, a move aimed at expanding its oncology pipeline. This strategic agreement coincides with the stock reaching record highs as investors show renewed interest in the healthcare sector. The deal provides a new catalyst for the company ahead of its scheduled third-quarter financial results release.